Dr. Ashish Kamat, MD

• Urology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Barisal Medical College

  Medical School, 1994

• Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis, 2017-08-29

• Micropapillary Bladder Cancer: Current Treatment Patterns and Review of the Literature, 2014-06-13

• Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy, 2020-06-23

• Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma, 2017-09-28

• Hospital Length of Stay following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Development and Validation of a Population-Based Prediction Model, 2018-11-13

• A novel FISH-based definition of BCG failure to enhance recruitment into clinical trials of intravesical therapies, 2015-07-03

• Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test, 2022-03-17

• New discoveries in the molecular landscape of bladder cancer [version 1; referees: 2 approved], 2016-12-19

• Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States, 2018-04-16

• The role of the urologist, BCG vaccine administration, and SARS-CoV-2: An overview, 2020-06-22

• Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer A cross-sectional study, 2016-08-07

• Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin, 2015-06-25

• Phase 1b trial to evaluate tissue response to a second dose of intravesical recombinant adenoviral interferon a2b formulated in Syn3 for BCG failures in non-muscle invasive bladder cancer, 2016-07-07

• Genetic Variations in the Sonic Hedgehog Pathway Affect Clinical Outcomes in Non-muscle-invasive Bladder Cancer, 2010-09-21

• Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients, 2018-06-06

• SALVAGE TOPICAL THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA, 2018-05-26

• Phase I Trial of Intravesical Recombinant Adenovirus-Mediated Interferon-a2b Formulated in Syn3 for BCG failures in Non-Muscle-Invasive Bladder Cancer, 2013-03-15

• Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer, 2018-08-17

• Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guerin Therapy: Implication for Clinical Trial Design, 2016-02-24

• Survival Differences Among Bladder Cancer Patients According to Gender: Critical Evaluation of Radical Cystectomy Use and Delay to Treatment, 2017-06-21

• Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients with Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy, 2011-02-26

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one National Harbor, MD, USA. 9-13 November 2016, 2016-11-16

• The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning, 2021-01-12

• Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis, 2021-08-30

• Advances in risk stratification of bladder cancer to guide personalized medicine [version 1; referees: 4 approved], 2018-07-25

• Use of Fluorescence in situ Hybridization to Predict Patient Response to BCG Therapy for Bladder Cancer: Results of a Prospective Trial, 2012-01-15

• Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma, 2017-08-15

• Data Sharing Under the General Data Protection Regulation Time to Harmonize Law and Research Ethics?, 2021-02-15

• Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial, 2021-12-18

• Increased Utilization of Positron Emission Tomography-Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed with Bladder Cancer, 2017-07-26

• Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guerin, 2020-03-04

• Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma, 2021-10-11

• The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review, 2017-11-07

• RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program, 2017-05-29

• Effects of Thiazolidinedione in Patients with Active Bladder Cancer, 2017-09-23

• Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer, 2019-12-01

• Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guerin Therapy Outcomes, 2021-04-29

• Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma, 2020-10-12

• Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013 Trends in Care, Surveillance, and Cost of Low-Grade Papillary NMIBC Among Older Adults, 2004-2013, 2022-03-18

• Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk, 2012-12-12

• Mitochondrial DNA Content as RiskFactorfor Bladder Cancer and its Association with Mitochondrial DNA Polymorphisms, 2015-04-20

• Novel PKC-? to p47phoxinteraction is necessary for transformation from blebbishields, 2016-04-04

• Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma, 2014-03-13

• GENETIC VARIANTS WITHIN THE WNT/ß-CATENIN SIGNALING PATHWAY AS INDICATORS OF BLADDER CANCER RISK, 2015-07-11

• Patient-Reported Outcomes are Associated with Enhanced Recovery Status in Patients with Bladder Cancer Undergoing Radical Cystectomy, 2018-03-20

• Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-Muscle Invasive Bladder Cancer, 2018-09-03

• Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer, 2016-03-15

• Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts, 2019-04-24

• Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin, 2017-09-23

• Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018, 2019-04-24

• Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 81 Cases, 2018-05-12

• Population-Based Assessment of Racial/Ethnic Differences in Utilization of Radical Cystectomy for Patients Diagnosed With Bladder Cancer, 2017-05-05

• Urachal carcinoma: a pathologic and clinical study of 46 cases, 2015-08-12

• Assessing the quality of studies on the diagnostic accuracy of tumor markers, 2014-08-20

• Bacillus Calmette Guerin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?, 2020-05-14